Transthyretin and Receptor for Advanced Glycation End Product’s Differential Levels Associated with the Pathogenesis of Rheumatoid Arthritis

References

• Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001.
   PubMed Web of Science ®Google Scholar
• WHO. Rheumatoid arthritis; 2018. Available from: www.who.int/chp/topics/rheumatic/en/. Accessed October 8, 2021.
   Google Scholar
• Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6:15.
   PubMed Web of Science ®Google Scholar
• Zavala-Cerna MG, Martínez-García EA, Torres-Bugarín O, et al. The clinical significance of posttranslational modification of autoantigens. Clinic Rev Allerg Immunol. 2014;47:73–90.
   PubMed Web of Science ®Google Scholar
• Santos AL, Lindner AB. Protein posttranslational modifications: roles in aging and age-related disease. Oxid Med Cell Longev. 2017;2017:5716409.
   PubMed Web of Science ®Google Scholar
• Sun F, Suttapitugsakul S, Xiao H, et al. Comprehensive analysis of protein glycation reveals its potential impacts on protein degradation and gene expression in human cells. J Am Soc Mass Spectrom. 2019;30:2480–2490.
   PubMed Web of Science ®Google Scholar
• Li X, Buxbaum JN. Transthyretin and the brain revisited: is a neuronal synthesis of transthyretin protective in Alzheimer’s disease? Mol Neurodegener. 2011;23(6):79.
   Google Scholar
• Gkogkolou P, Bohm M. Advanced glycation end products: key players in skin ageing? Dermatoendocrinol. 2012;4(3):259–270.
   PubMedGoogle Scholar
• Tarannum A, Arif Z, Alam K, Ahmad S, Uddin M. Nitroxidized-albumin advanced glycation end product and rheumatoid arthritis. Arch Rheumatol. 2019;34(4):461–475.
   PubMed Web of Science ®Google Scholar
• Luzak B, Boncler M, Kosmalski M, et al. Fibrinogen glycation and presence of glucose impair fibrin polymerization-an in vitro study of isolated fibrinogen and plasma from patients with diabetes mellitus. Biomolecules. 2020;10(6):877.
   PubMed Web of Science ®Google Scholar
• Kennedy DM, Skillen AW, Self CH. Glycation of monoclonal antibodies impairs their ability to bind antigen. Clin Exp Immunol. 1994;98:245–251.
   PubMed Web of Science ®Google Scholar
• Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 2014;18(1):1–14.
   PubMed Web of Science ®Google Scholar
• Parker CE, Mocanu V, Mocanu M, et al. Mass Spectrometry for post-translational modifications. In: Alzate O, editor. Neuroproteomics. Boca Raton (FL): CRC Press/Taylor & Francis; 2010.
   Google Scholar
• Krasny L, Bland P, Kogata N, et al. SWATH mass spectrometry as a tool for quantitative profiling of the matrisome. J Proteomics. 2018;189:11–22.
   PubMed Web of Science ®Google Scholar
• Pereira Morais MP, Marshall D, Flower SE, et al. Analysis of protein glycation using fluorescent phenyl-boronate gel electrophoresis. Sci Rep. 2013;3(2013):1437.
   PubMedGoogle Scholar
• Lee EJ, Park JH. Receptor for Advanced Glycation Endproducts (RAGE), its ligands, and soluble RAGE: potential biomarkers for diagnosis and therapeutic targets for human renal diseases. Genomics Inform. 2013;11(4):224–229.
   PubMedGoogle Scholar
• Hua C, Daien CI, Combe B, Landewe R. Diagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis. RMD Open. 2017;3(1):e000406.
   PubMedGoogle Scholar
• Biswas S, Sharma S, Saroha A, et al. Identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immune-proteomics approach. PLoS One. 2013;8(2):e56246.
   PubMed Web of Science ®Google Scholar
• Monu, Kharb R, Sharma A, Chaddar MK, et al. Plasma proteome profiling of coronary artery disease patients: downregulation of transthyretin-an important event. Mediators Inflamm. 2020;2020:3429541.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Ames JM, Smith RD, Baynes JW, Metz TO. A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of the chronic disease. J Proteome Res. 2009;8(2):754–769.
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–461.
   PubMed Web of Science ®Google Scholar
• Donato R. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med. 2007;7:711–724.
   PubMed Web of Science ®Google Scholar
• de Groot L, Hinkema H, Westra J, et al. Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease. Arthritis Res Ther. 2011;13(6):R205.
   PubMed Web of Science ®Google Scholar
• Kong QZ, Guo LT, Yang JN, et al. Anti-inflammatory effects of TRAF-interacting protein in rheumatoid arthritis fibroblast-like synoviocytes. Mediators Inflamm. 2016;2016:3906108.
   PubMed Web of Science ®Google Scholar
• Zhou L, Tang X, Li X, Bai Y, Buxbaum JN, Chen G. Identification of transthyretin as a novel interacting partner for the δ subunit of GABAA receptors. PLoS One. 2019;14(1):e0210094.
   PubMed Web of Science ®Google Scholar
• Tan EM, Smolen JS. Historical observations contributing insights on the etiopathogenesis of rheumatoid arthritis and the role of rheumatoid factor. J Exp Med. 2016;213(10):1937–1950.
   PubMed Web of Science ®Google Scholar
• Zhang R, Yang X, Wang J, et al. Identification of potential biomarkers for differential diagnosis between rheumatoid arthritis and osteoarthritis via integrative genome‑wide gene expression profiling analysis. Mol Med Rep. 2019;19(1):30–40.
   PubMed Web of Science ®Google Scholar
• Ott C, Jacobs K, Haucke E, et al. Role of advanced glycation end products in cellular signalling. Redox Biol. 2014;2:411–429.
   PubMed Web of Science ®Google Scholar
• Ansari NA, Dash D. Amadori glycated proteins: role in the production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation. Aging Dis. 2013;4:50–56.
   PubMed Web of Science ®Google Scholar
• Arasteh A, Farahi S, Habibi-Rezaei M, Moosavi-Movahedi AA. Glycated albumin: an overview of the in vitro models of an in vivo potential disease marker. J Diabetes Metab Disord. 2014;13:49.
   PubMedGoogle Scholar
• Spiller S, Li Y, Blüher M, Welch L, Hoffmann R. Diagnostic accuracy of protein glycation sites in long-term controlled patients with Type 2 diabetes mellitus and their prognostic potential for early diagnosis. Pharmaceuticals (Basel). 2018;11(2):38.
   PubMedGoogle Scholar
• Nobecourt E, Tabet F, Lambert G, et al. Nonenzymatic glycation impairs the anti-inflammatory properties of apolipoprotein A-I. Arterioscler Thromb Vasc Biol. 2010;30(4):766–772.
   PubMed Web of Science ®Google Scholar
• Sabitha D, Dawson E, Tiwari S, et al. Study of glycation of transferrin and its effect on biomarkers of iron status in uncontrolled diabetes mellitus patients. J Clin Diagn Res. 2020;14(2020):BC06–BC09.
   Google Scholar
• Buxbaum JN, Reixach N. Transthyretin: the servant of many masters. Cell Mol Life Sci. 2009;66(19):3095–3101.
   PubMed Web of Science ®Google Scholar
• Azevedo EP, Guimaraes-Costa AB, Bandeira-Melo C, et al. Inflammatory profiling of patients with familial amyloid polyneuropathy. BMC Neurol. 2019;19(1):146.
   PubMedGoogle Scholar
• Bobbert T, Raila J, Schwarz F, et al. Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima-media thickness. Atherosclerosis. 2010;213(2):549–551.
   PubMed Web of Science ®Google Scholar
• Mahmud SA, Binstadt BA. Autoantibodies in the pathogenesis, diagnosis, and prognosis of juvenile idiopathic arthritis. Front Immunol. 2019;9:3168.
   PubMed Web of Science ®Google Scholar
• Pullerits R, Bokarewa M, Dahlberg L, et al. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther. 2005;7(4):R817–R824.
   PubMed Web of Science ®Google Scholar
• Drinda S, Franke S, Eidner T, et al. Decreased RAGE expression in peripheral blood mononuclear cells of patients with rheumatoid arthritis. Clin Exp Rheumatol. 2009;27(3):483–490.
   PubMed Web of Science ®Google Scholar
• Lin J, He Y, Chen J, Zeng Z, Bin Y, Ou Q. Datasets of YY1 expression in rheumatoid arthritis patients. Data Brief. 2016;9:1034–1038.
   PubMedGoogle Scholar
• Yoshitomi H. Regulation of immune responses and chronic inflammation by fibroblast-like synoviocytes. Front Immunol. 2019;19(10):1395.
   Google Scholar
• Tobon-Velasco JC, Cuevas E, Torres-Ramos MA. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord Drug Targets. 2014;13(9):1615–1626.
   PubMed Web of Science ®Google Scholar
• Huang JS, Guh JY, Chen HC, Hung WC, Lai YH, Chuang LY. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J Cell Biochem. 2001;81(1):102–113.
   PubMed Web of Science ®Google Scholar